Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai.
History
Glenmark Pharmaceuticals was founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer. He named the company after his two sons. The company initially sold its products in India, Russia, and Africa. The company went public in India in 1999. Saldanha's son Glenn took over as CEO in 2001,[5] having returned to India after working at PricewaterhouseCoopers.[6] In 2008 Glenmark was the fifth-biggest pharmaceutical company in India.[7]
By 2011 the founder of the company was one of the richest men in India,[8] and Glenmark had worldwide sales of $778 million, a 37% increase over the last year's sales; the growth was driven by Glenmark's entry into the US and European generics markets.